Sinopharm Group Buys Hebei Medicine Retailer for $197 Million, Plans at Least $759 Million of Acquisitions in Next Two Years

Jan 26 (Reuters) - Sinopharm Group Co Ltd (1099.HK) said on Wednesday it would buy a majority stake in a medicines retail chain operator for up to 1.3 billion yuan ($197.5 million), a bid to expand its pharmaceutical distribution business in China's Hebei province.
MORE ON THIS TOPIC